Application no. and date | 18183208.0 (espacenet) (Federated) (European Patent Register), 20131120 | Patent/reg. no. and date | DK/EP 3444281, 20211103 | Publication date | 20190220 | Priority no. and date | US 201261728667 P, 20121120 | EP pub. no. and date |
EP 3444281 20190220 | Effective date | | Applicant/owner | Eumederis Pharmaceuticals, Inc., 12707 High Bluff Drive, Suite 200
San Diego, CA 92130, US | Applicant ref. no. | 1624608 | Inventor | NESTOR, John, J, 7515 Guinevere Drive
Sugar Land, TX 77479, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 38/00 (2006.01) , A61K 38/07 (2006.01) , A61K 38/08 (2019.01) , A61K 38/26 (2006.01) , A61K 38/29 (2006.01) , C07K 1/107 (2006.01) , C07K 19/00 (2006.01) , C07K 5/065 (2006.01) , C07K 7/06 (2006.01) , C09D 101/28 (2006.01) | Title | FORBEDREDE PEPTIDLÆGEMIDLER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|